Search

everythinglearnresearchcommunity

for

Search:↓

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Minoxidil helps hair regrowth by stimulating hair follicles and reducing immune responses.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

HuR is essential for Treg function and preventing autoimmunity.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Hair follicles regulate immune cells in the skin, and disrupting certain pathways can lead to skin issues and infections.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

Certain biomarkers can help distinguish between irritant and allergic contact dermatitis.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Plucked hair follicles can help diagnose scalp lupus.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Certain immune cells in the skin can stop hair from growing.

Some drugs used to treat immune conditions may cause different types of hair loss.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

FoxN1 overexpression in young mice harms immune cell and skin development.

Sudden hair whitening may be linked to immune system activity.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.